Chesnara plc (LON:CSN – Get Rating) insider David Rimmington sold 30,153 shares of the firm’s stock in a transaction that occurred on Thursday, May 18th. The shares were sold at an average price of GBX 276 ($3.46), for a total value of £83,222.28 ($104,249.38).
Chesnara Stock Up 0.5 %
CSN opened at GBX 281.38 ($3.52) on Friday. The stock’s 50 day moving average price is GBX 283.99 and its 200 day moving average price is GBX 283.76. The company has a debt-to-equity ratio of 64.01, a current ratio of 9.18 and a quick ratio of 38.06. The stock has a market cap of £423.17 million, a P/E ratio of -433.85 and a beta of 0.44. Chesnara plc has a 12 month low of GBX 259 ($3.24) and a 12 month high of GBX 334.40 ($4.19).
Chesnara Increases Dividend
The company also recently declared a dividend, which will be paid on Friday, May 26th. Shareholders of record on Thursday, April 6th will be paid a dividend of GBX 15.16 ($0.19) per share. This is a positive change from Chesnara’s previous dividend of $8.12. This represents a yield of 5.42%. The ex-dividend date is Thursday, April 6th. Chesnara’s dividend payout ratio (DPR) is presently -4,615.38%.
Chesnara plc, together with its subsidiaries, engages in the life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through CA, Movestic, Waard Group, and Scildon segments. The company underwrites life risks, such as death, disability, health, and accident; and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management, as well as general insurance products.
- It’s Time To Take Another Bite Of Take-Two Interactive
- Zoetis Declares New Dividend, Hinting At Undervaluation
- Good News For Walmart Isn’t So Great For Everybody Else
- Eagle Materials, Answering America’s Building Supply Needs
- Pharma Giants Novartis, Lilly, Merck, and Novo Outperform Market
Receive News & Ratings for Chesnara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara and related companies with MarketBeat.com's FREE daily email newsletter.